Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

ADVOCACY UPDATES

Medicare Physician Payment

AMA Advocacy Update The House of Representatives voted 339-85 on March 6 to pass the…

Read more

Medicare Advantage FAQ

The Centers for Medicare & Medicaid Services recently sent a memo to Medicare Advantage (MA)…

Read more

AMA National Survey to Document Physician Practice Expense Is Still Open

Please take the time to complete the Physician Practice Information Survey! If you or your…

Read more

Upcoming Dates

04/01/24: Fellow Exam Application Deadline
Learn more

06/01/24: Research Grant Cycle
Learn more

06/25/24: Membership Application Deadline to be eligible for AAOA Member rate for the 2024 Basic Course

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

EDUCATION

AAOA Advanced Course

The recorded course content is available until April 30, 2024. This year’s Advanced Course featured Laryngology and Skull Base Surgery with Nausheen Jamal, MD and Garret Choby, MD as featured faculty.

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Content Access Deadline:
April 30, 2024
Learn More and Register

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Register

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register 

2025 AAOA Advanced Course in Allergy & Immunology - Hybrid
March 27-29, 2025
The Hythe, Vail, CO
Book Your Room

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Available April 1 - June 1, 2024

News and Updates

CEO Update, February 2024

Funny how there are so many metaphors for life in some of our day-to-day activities. …

Read more

US ENT Partners Announces Strategic Relationship With AAOA

by Keith E. Matheny, M.D., F.A.R.S. via LinkedIn US ENT Partners, a Group Purchasing Organization…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Do I Need an Antihistamine and an Intranasal Steroid?

By James Connolly, MD, FAAOA

Allergic rhinitis is caused by many different antigens. Some  antigen exposure seasonal (limited exposure during the year such as ragweed or tree pollen), and some antigen exposure is year around or perennial, such as dust mites, cat dander, or mold. Each patient also has different levels of severity of their sensitivity or reactions to each antigen. Both factors can affect symptoms and need for additional therapy.

Allergic reactions are made up of two phases: the acute-phase and the delayed-phase inflammation. The acute phase occurs at the site of exposure when the mast cell degranulates, releasing histamines, and causing itching and swelling at the location of exposure. Poison ivy is a good example of acute phase.  Antihistamines work well to block this phase and decrease acute symptoms.

Intranasal steroids are corticosteroids that block the delayed inflammatory phase, inhibiting release of prostaglandins, leukotrienes, and cytokines. These mediators cause a second wave of symptoms and are delivered from immune cells far away from the local exposure site. The majority of symptoms related to allergy (nasal congestion, runny nose, itchy eyes) are a result of this delayed response. The secondary swelling can occur over days and weeks and plays a larger role in repeat exposures.

For patients having mild non-daily reactions from seasonal allergy, antihistamines alone can be all they need. For those patients suffering from daily symptoms and specifically, perennial allergy exposure, intranasal steroids are the most helpful. If nasal steroids alone are not controlling these symptoms, an antihistamine nasal sprays can provide additional control, but oral antihistamines do not offer any additional benefit. 

For those patients with persistent congestion and swelling or underlying asthma, adding an anti-leukotriene, such as montelukast can also be helpful. 

Back To Top